Strategic Board C2Sense recently added high-profile science and healthcare leadership to its board, including Dr. Michael Mina. This indicates growing credibility and potential for partnerships with clinical institutions and health organizations seeking advanced diagnostics and authentication solutions.

Halo Platform The Halo technology platform for rapid diagnostics and product viability offers a clear entry point for customers in medical device manufacturing, pharmaceutical supply chains, and consumer health products that require authentication and integrity checks.

Proof of Concept Past PoC showcases for SARS-CoV-2 detection demonstrate real-world validation capabilities, suggesting opportunities to license or co-develop rapid test solutions with health tech firms, research labs, and government-related health programs.

Small Team, Niche With 11-50 employees and a focus on advanced optical sensing, C2Sense represents a specialized partner for boutique medical equipment manufacturers seeking scalable sensing integration or bespoke diagnostic modules.

Funding & Traction Historical seed funding and strategic advisor presence signal potential for collaboration on grant-backed R&D, pilot projects, or contract research with universities, biotech firms, and incubators aligned to tough-tech sensing.